A carregar...
Beta-blockers in cirrhosis: Evidence-based indications and limitations
Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in preventing initial variceal bleeding and subsequent rebleeding. Recent evidence indicates that NSBBs could prevent...
Na minha lista:
| Publicado no: | JHEP Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7005550/ https://ncbi.nlm.nih.gov/pubmed/32039404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.12.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|